Related Experiment Videos
Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci
European Journal of Clinical Microbiology
|April 1, 1987
Abstract:
The antistaphylococcal activity of LY146032 was tested in human pus in vitro and in a murine abscess model in vivo. The drug was not degraded by pus containing beta-lactamase and had equally good or better activity than nafcillin or vancomycin against Staphylococcus aureus or Staphylococcus epidermidis in vitro and in vivo. Its activity was slightly enhanced when used in combination with rifampin and tobramycin.
Insights
LY146032 demonstrates potent antistaphylococcal activity in human pus and a murine abscess model. This novel antibiotic shows efficacy comparable or superior to nafcillin and vancomycin, even in the presence of beta-lactamase.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Staphylococcus aureus and Staphylococcus epidermidis are significant human pathogens.
- Beta-lactamase-producing strains pose treatment challenges.
- Novel antibiotics with broad antistaphylococcal activity are needed.
Purpose of the Study:
- To evaluate the antistaphylococcal activity of LY146032.
- To assess LY146032's stability and efficacy in human pus and a murine abscess model.
- To investigate the effect of combination therapy with LY146032.
Main Methods:
- In vitro testing of LY146032 in human pus.
- In vivo evaluation using a murine abscess model.
- Comparison with nafcillin and vancomycin.
Main Results:
- LY146032 was stable in pus containing beta-lactamase.
- LY146032 exhibited equal or superior activity against S. aureus and S. epidermidis compared to nafcillin and vancomycin.
- Combination therapy with rifampin and tobramycin slightly enhanced LY146032's activity.
Conclusions:
- LY146032 possesses significant antistaphylococcal properties.
- The drug is effective in challenging conditions, including beta-lactamase-positive environments.
- LY146032 is a promising candidate for treating staphylococcal infections.